Pfizer recently announced that it has received marketing approval from the US Food and Drug Administration for voriconazole (Vfend tablets) and voriconazole for injection (Vfend I.V.) for use in the treatment of invasive aspergillosis and the treatment of serious fungal infections caused by Scedosporium apiospermum and Fusarium spp in patients intolerant of, or refractory to, other therapy.
Avonex covered under Medicare's self-injectable policy
The US Food and Drug Administration (FDA) recently approved urofollitropin for injection, purified (Bravelle, Ferring Pharmaceuticals) for the treatment of infertility. Urofollitropin is a highly purified follicle-stimulating hormone derived from the urine of postmenopausal women
Pharmacists are facing a myriad of prescription discount cards in a high-stakes game
nacds launches pharmacy care index to aid patient compliance
nacds promotes pharmacy to his students
Medicare bill considers paying for oral cancer drugs
Georgia bill regulates PBMs
APA releases new guidelines to treat bipolar disorder.
Handheld devices let physicians compare drug prices when they are prescribing
NIOSH to publish safety alert related to cytotoxic drugs
Feds post quality of nursing homes on Web for consumers to comparison shop
Pharmacists feel they're gaining authority in some areas and lagging in others
PDUFA law renewal draws consumer protest
American Pain Society recommends using OxyContin to treat patients with arthritis.
Executives from Merck-Medco and Rite Aid speak at AMCP meeting on how to build constructive relationship with each other
drug topics selects costco as pharmacy chain of the year 2002
New Mexico law will allow psychologists to prescribe
New guidelines treat breast cancer.
NACDS proposes a one-card program but pharmacists have mixed reactions
pharmacy benefits trends in US
On March 8, 2002, the FDA announced the approval of interferon beta-1a (Rebif, Serono) for the treatment of relapsing forms of MS. The FDA based its approval on the results of two trials.
Community pharmacy rejected the Bush administration's new plan for Medicare Rx discount cards as a rehash of the first proposal unveiled in July, 2001.
An alphabet soup of suffixes has arisen for controlled-release drugs, increasing the potential for drug errors
There's an alphabet soup of titles for the pharmacy profession now
VA pharmacists may have to give up their prescriptive authority unless their state allows the practice
Walter Fitzgerald speaks on Third Party Contracting: Understanding the Deal at NCPA conference in Vegas 2002
walgreens and cvs launch new advertising campaigns in 2002
The Delaware Pharmacist Society has partnered on several projects that pay pharmacists for their services.
ASHP is alarmed by JCAHO's proposed standard that eliminates the prospective check by an R.Ph. when an Rx is generated by a computerized physician order entry systems.
